28.01.2014 Views

Pesticide residues in food — 2006: Toxicological ... - ipcs inchem

Pesticide residues in food — 2006: Toxicological ... - ipcs inchem

Pesticide residues in food — 2006: Toxicological ... - ipcs inchem

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

548<br />

•<br />

•<br />

•<br />

Chromosomal aberration <strong>in</strong> Ch<strong>in</strong>ese hamster V79 cells;<br />

Unscheduled DNA synthesis <strong>in</strong>duction <strong>in</strong> primary rat hepatocytes; and<br />

Micronucleus <strong>in</strong>duction <strong>in</strong> bone-marrow cells of mice treated <strong>in</strong> vivo.<br />

Therefore, the available evidence <strong>in</strong>dicated that genotoxicity is not an alternative mode of<br />

action for thiacloprid.<br />

Tests <strong>in</strong> vitro did not reveal any <strong>in</strong>hibit<strong>in</strong>g effect on enzymes <strong>in</strong>volved <strong>in</strong> steroid degradation,<br />

so that an accumulation of estradiol was not the reason for the changes <strong>in</strong> serum hormone levels.<br />

However, there was an <strong>in</strong>duction of enzymes which catalyse the conversion of testosterone to<br />

androstendione, which may have contributed to <strong>in</strong>creased production of estradiol.<br />

2.9 Uncerta<strong>in</strong>ties, <strong>in</strong>consistencies, and data gaps<br />

No <strong>in</strong>consistencies were identified <strong>in</strong> the database for thiacloprid with regard to the postulated<br />

mode of action for uter<strong>in</strong>e adenocarc<strong>in</strong>omas <strong>in</strong> rats. However, the data <strong>in</strong>dicat<strong>in</strong>g an <strong>in</strong>crease <strong>in</strong> serum<br />

estradiol levels as a result of exposure to thiacloprid are limited s<strong>in</strong>ce this end-po<strong>in</strong>t was <strong>in</strong>vestigated<br />

only <strong>in</strong> a mechanistic study.<br />

2.10 Assessment of postulated mode of action<br />

The data presented are considered, with a moderate degree of confidence, to be adequate to<br />

expla<strong>in</strong> that thiacloprid exerts its carc<strong>in</strong>ogenic effect on the rat uterus secondary to <strong>in</strong>duction of hepatic<br />

aromatase activity lead<strong>in</strong>g to <strong>in</strong>creased serum estradiol levels and prolonged uter<strong>in</strong>e endometrium<br />

stimulation.<br />

2.11 Conclusion<br />

There is experimental evidence that thiacloprid <strong>in</strong>duces uter<strong>in</strong>e adenocarc<strong>in</strong>omas <strong>in</strong> rats<br />

by a process <strong>in</strong>clud<strong>in</strong>g <strong>in</strong>duction of hepatic aromatase and prolonged stimulation of the uter<strong>in</strong>e<br />

endometrium by <strong>in</strong>creased concentrations of serum estrogen. Although the postulated mode of<br />

action could theoretically operate <strong>in</strong> humans, the particular sensitivity of rats for neoplasia ow<strong>in</strong>g to<br />

<strong>in</strong>creased estradiol levels over a longer period of time allows for the conclusion that thiacloprid does<br />

not pose a carc<strong>in</strong>ogenic risk to humans at exposure levels relevant to <strong>residues</strong> <strong>in</strong> <strong>food</strong>.<br />

3. Ovarian luteomas <strong>in</strong> mice<br />

3.1 Introduction<br />

In the long-term study of carc<strong>in</strong>ogenicity <strong>in</strong> mice, <strong>in</strong>creased <strong>in</strong>cidences of ovarian luteomas were<br />

observed <strong>in</strong> females at dietary concentrations of 1250 and 2500 ppm, equal to 475 or 873 mg/kg bw per<br />

day (see monograph section 2.3).<br />

3.2 Postulated mode of action (theory of the case)<br />

The postulated mode of action for thiacloprid-<strong>in</strong>duced ovarian luteomas <strong>in</strong>volves hormonal<br />

disruption caused secondarily by effects on the liver. Specifically, thiacloprid is a strong <strong>in</strong>ducer of<br />

hepatic microsomal cytochrome P450 enzymes, <strong>in</strong>clud<strong>in</strong>g aromatase, a key enzyme <strong>in</strong> the synthesis<br />

THIACLOPRID X-X JMPR <strong>2006</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!